Ning Li
- Molecular Biology top 10%
- Oncology top 5%
- Radiology, Nuclear Medicine and Imaging top 2%
- Immunology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Topics
- Lung Cancer Treatments and Mutations (32 papers)Monoclonal and Polyclonal Antibodies Research (26 papers)Cancer Genomics and Diagnostics (24 papers)
- Journals
- Nature CommunicationsJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Ning Li
148 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 136
- Molecular Biology 932
- Oncology 768
- Radiology, Nuclear Medicine and Imaging 559
- Immunology 558
- Pulmonary and Respiratory Medicine 476
Countries citing papers authored by Ning Li
This map shows the geographic impact of Ning Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ning Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ning Li more than expected).
Fields of papers citing papers by Ning Li
This network shows the impact of papers produced by Ning Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ning Li. The network helps show where Ning Li may publish in the future.
Co-authorship network of co-authors of Ning Li
This figure shows the co-authorship network connecting the top 25 collaborators of Ning Li. A scholar is included among the top collaborators of Ning Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ning Li. Ning Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 22 | |
| 6 | 17 | |
| 7 | 3 | |
| 8 | 2 | |
| 9 | 2 | |
| 10 | 17 | |
| 11 | 3 | |
| 12 | 4 | |
| 13 | 19 | |
| 14 | 2 | |
| 15 | 5 | |
| 16 | 10 | |
| 17 | 2 | |
| 18 | 1 | |
| 19 | 35 | |
| 20 | 47 |
About Ning Li
Ning Li is a scholar working on Oncology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 164 papers that have together received 2.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (32 papers), Monoclonal and Polyclonal Antibodies Research (26 papers) and Cancer Genomics and Diagnostics (24 papers). The work is most often cited by research in Oncology (768 citations), Immunology (558 citations) and Radiology, Nuclear Medicine and Imaging (559 citations). Ning Li has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Shuhang Wang, Peiwen Ma, Huilei Miao, Huiyao Huang, Yan Zha, Yuan Fang, Shujun Xing, Qiyu Tang, Ning Jiang and Kun Chen. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.